Oppenheimer cuts Prothena stock rating after trial setback

[
Oppenheimer cuts Prothena stock rating after trial setback
[og_img]
https://www.investing.com/news/analyst-ratings/oppenheimer-cuts-prothena-stock-rating-after-trial-setback-93CH-4064244

Investing.com

Telegram gets some AI integration but you may not love the source

Microsoft wants to simplify all Windows updates, and it could make everyone’s life easier

Nvidia RTX 5050 GPU spotted in Acer gaming laptops, so it could arrive soon – but I’m becoming more doubtful about a desktop variant

Millions of users could fall for fake Facebook ad for a text-to-AI-video tool that is just malware

Ex-Israeli Intelligence Official: Shockwaves of Trump’s “Take Over Gaza” Heard, Felt Across Region

What UK political parties are promising in the 2019 general election

Otto Warmbier’s parents want North Korea to suffer for their son’s death

Could a ‘youthquake’ cause Boris Johnson to lose the general election?

Which Celebrity Styles Americans Copy Most in 2025: New Study

New ‘Westworld’ trailer introduces us to another dystopian tech company

What’s the point of ‘Charlie’s Angels’ without Sam Rockwell dancing?

These striking photos capture the future of human flight

US judge blocks Trump from halting Biden-era migrant 'parole' programs

Applovin's CTO Shikin Vasily sells $12.3m in stock

Paramount has offered $15 million to settle CBS lawsuit, WSJ reports

US cancels more than $700 million funding for Moderna bird flu vaccine

The YouTuber who has become one of Gen Z’s most beloved celebrities

26 last-minute holiday gifts that are still thoughtful and unique

Practicing gratitude regularly can make you less stressed and sleep better

8 things millennials wish you would just stop getting them for the holidays

Oppenheimer cuts Prothena stock rating after trial setback

US judge blocks Trump from halting Biden-era migrant 'parole' programs

Applovin's CTO Shikin Vasily sells $12.3m in stock

Paramount has offered $15 million to settle CBS lawsuit, WSJ reports

US cancels more than $700 million funding for Moderna bird flu vaccine

Leave a reply Cancel reply